Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension Trial

Autor: Buynak, Robert, Rappaport, Stephen A., Rod, Kevin, Arsenault, Pierre, Heisig, Fabian, Rauschkolb, Christine, Etropolski, Mila
Zdroj: In Clinical Therapeutics 1 November 2015 37(11):2420-2438
Databáze: ScienceDirect